Efficacy and safety of esaxerenone (CS-3150) in Japanese patients with type 2 diabetes and macroalbuminuria: a multicenter, single-arm, open-label phase III study

被引：0
|
作者：
Sadayoshi Ito
Naoki Kashihara
Kenichi Shikata
Masaomi Nangaku
Takashi Wada
Yasuyuki Okuda
Tomoko Sawanobori
机构：
[1] Tohoku University School of Medicine,Division of Nephrology, Endocrinology and Vascular Medicine, Department of Medicine
[2] Katta General Hospital,Center for Innovative Clinical Medicine
[3] Department of Nephrology and Hypertension,Division of Nephrology and Endocrinology, Graduate School of Medicine
[4] Kawasaki Medical School,Department of Nephrology and Laboratory Medicine
[5] Okayama University Hospital,Data Intelligence Department
[6] The University of Tokyo,Clinical Development Department
[7] Kanazawa University,undefined
[8] Daiichi Sankyo Co.,undefined
[9] Ltd.,undefined
[10] Daiichi Sankyo Co.,undefined
[11] Ltd.,undefined
来源：
Clinical and Experimental Nephrology | 2021年 / 25卷
关键词：
Esaxerenone; Macroalbuminuria; Phase III; Type 2 diabetes; Urinary albumin-to-creatinine ratio;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1070 / 1078
页数：8
相关论文
共 50 条
  • [11] Safety and efficacy of elapegademase in patients with adenosine deaminase deficiency: A multicenter, open-label, single-arm, phase 3, and postmarketing clinical study
    Onodera, Masafumi
    Uchiyama, Toru
    Ariga, Tadashi
    Yamada, Masafumi
    Miyamura, Takako
    Arizono, Hironori
    Morio, Tomohiro
    IMMUNITY INFLAMMATION AND DISEASE, 2023, 11 (07)
  • [12] Efficacy and safety of sorafenib in combination with gemcitabine in patients with advanced hepatocellular carcinoma: A multicenter, open-label, single-arm phase II study
    Srimuninnimit, Vichien
    Sriuranpong, Virote
    Suwanvecho, Suthida
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 (03) : 255 - 260
  • [13] Safety, tolerability and efficacy of lixisenatide as monotherapy in Japanese patients with type 2 diabetes mellitus: An open-label, multicenter study
    Seino, Yutaka
    Terauchi, Yasuo
    Wang, Xiangling
    Watanabe, Daisuke
    Niemoeller, Elisabeth
    JOURNAL OF DIABETES INVESTIGATION, 2018, 9 (01) : 108 - 118
  • [14] Nintedanib for patients with lymphangioleiomyomatosis: a phase 2, open-label, single-arm study
    Harari, Sergio
    Elia, Davide
    Caminati, Antonella
    Geginat, Jens
    Luisi, Francesca
    Pelosi, Giuseppe
    Specchia, Claudia
    Torre, Olga
    Trevisan, Roberta
    Vasco, Chiara
    Zompatori, Maurizio
    Cassandro, Roberto
    LANCET RESPIRATORY MEDICINE, 2024, 12 (12): : 967 - 974
  • [15] Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study
    Namikawa, Kenjiro
    Kiyohara, Yoshio
    Takenouchi, Tatsuya
    Uhara, Hisashi
    Uchi, Hiroshi
    Yoshikawa, Shusuke
    Takatsuka, Sumiko
    Koga, Hiroshi
    Wada, Naoko
    Minami, Hironobu
    Hatsumichi, Masahiro
    Asada, Suguru
    Namba, Yoshinobu
    Yamazaki, Naoya
    EUROPEAN JOURNAL OF CANCER, 2018, 105 : 114 - 126
  • [16] Safety and Efficacy of Iguratimod in Patients with Active Rheumatoid Arthritis: A Multicenter, Single-Arm, Open-Label, Real World Study
    Mu, Rong
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [17] Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study
    Shuichi Ito
    Yuya Nishiyama
    Kenkichi Sugiura
    Kazuaki Enya
    Clinical and Experimental Nephrology, 2022, 26 : 350 - 358
  • [18] Efficacy and Safety of Esaxerenone (CS-3150) for the Treatment of Type 2 Diabetes with Microalbuminuria: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial
    Ito, Sadayoshi
    Shikata, Kenichi
    Nangaku, Masaomi
    Okuda, Yasuyuki
    Sawanobori, Tomoko
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (08): : 1161 - 1172
  • [19] Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are intolerant to ruxolitinib: A single-arm, open-label, phase 2, multicenter study
    Zhang, Yi
    Zhou, Hu
    Duan, Minghui
    Gao, Sujun
    He, Guangsheng
    Jing, Hongmei
    Li, Junmin
    Ma, Liangming
    Zhu, Huanling
    Chang, Chunkang
    Du, Xin
    Hong, Mei
    Li, Xin
    Liu, Qingchi
    Wang, Wei
    Xu, Na
    Yang, Haiping
    Lu, Binhua
    Yin, Hewen
    Wu, Liqing
    Suo, Shanshan
    Zhao, Qingwei
    Xiao, Zhijian
    Jin, Jie
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, : 1588 - 1597
  • [20] Evaluation of safety and efficacy of intravenous zanamivir in the treatment of hospitalized Japanese patients with influenza: an open-label, single-arm study
    Watanabe, Akira
    Yates, Phillip J.
    Murayama, Marie
    Soutome, Toru
    Furukawa, Hiroiku
    ANTIVIRAL THERAPY, 2015, 20 (04) : 415 - 423
12345